Viavi Solutions is trading 5.36% higher at $29.29 in pre-market, with no clearly reported company-specific announcement explaining the move.

  • Investors are looking ahead to fiscal first-quarter 2027 results, scheduled for November 4 after the market close; the report is context, not a confirmed catalyst for the rise.
  • Available evidence does not establish a broader-market cause either.